Baxter Issues Correction for Novum IQ Infusion Pump Over Underinfusion Risk
The correction follows reports that extended standby time or leaving the pump powered off with an administration set loaded may reduce flow delivery.
The correction follows reports that extended standby time or leaving the pump powered off with an administration set loaded may reduce flow delivery.
The U.S. FDA has cleared the Baxter Novum IQ's large volume infusion pump with Dose IQ Safety Software, offering an integrated system alongside Baxter's syringe infusion pump to streamline patient care across various settings.
Amid continued recall concerns, devices from Medtronic and Baxter were recently assigned the most serious recall type be the FDA.
The correction follows reports that extended standby time or leaving the pump powered off with an administration set loaded may reduce flow delivery.
Baxter has initiated a safety recall for its Spectrum Dose IQ Safety Software due to a potentially life-threatening defect in which incorrect drug-dosing information could be transmitted to the company’s Spectrum IQ Infusion System. The potential for patient harm is so serious, in fact, that the U.S. FDA has categorized it as a Class 1 recall.
Read MoreAccording to sources close to the matter, Deerfield, Ill.-based medical technology company Baxter is in talks to purchase Chicago-based Hill-Rom, which manufactures hospital beds and patient monitoring equipment.
Read MoreAK 98 offers encrypted, two-way connectivity, which enables the system to pull prescriptions directly from the EMR for simplified workflow and data handling.
Read More